Divya Jha
@divyajha_phd
Followers
45
Following
1
Media
0
Statuses
8
Immunologist @sinaiimmunol @MehandruLab (via @NImmunology)
Joined September 2020
Colorful section of colon biopsy, image courtesy of @a_livanos and @divyajha_phd Acquired with @LeicaMicro SP8 confocal 🔬 #microscopy #confocal #imaging
0
3
11
Great work from @MehandruLab & congrats on this #PosterOfDistinction at #DDW2024! @divyajha_phd walks us through the intricate role of cellular dynamics within the epithelial compartment and their impact on treatment responses of therapies used in #ulcerativecolitis management.
0
3
17
Thank you to all our amazing collaborators including @petra_fra @DataDrivenMayte @CArgmann @JeanFredericCo1 @CHUnantes and all @MehandruLab members!! 🔥🔥
0
1
1
We are very excited to share our preprint out now in @biorxivpreprint lead by @divyajha_phd!! We describe how epithelium-associated myeloid cells in ulcerative colitis impact response to anti-TNF therapy @SinaiImmunol @MountSinaiGI @IcahnMountSinai
https://t.co/Oc2hEIcEoE
biorxiv.org
Ulcerative colitis (UC) is an idiopathic chronic inflammatory disease of the colon with sharply rising global prevalence. Dysfunctional epithelial compartment (EC) dynamics are implicated in UC...
1
11
25
We are excited to share our work out now in @NatureMedicine, where we describe a dysregulated B cell response in Ulcerative colitis patients. Congrats to @mat_uzz, Jerome Martin and everyone involved in this project!
6
36
179
1. Highlights from our recent preprint: Quantification of discrete gut bacterial strains following fecal transplantation for recurrent Clostridioides difficile infection demonstrates long-term stable engraftment in non-relapsing recipients
biorxiv.org
Fecal Microbiota Transplantation (FMT), while successful for the treatment of recurrent Clostridioides difficile (rCDI) infection, lacks a quantitative identification of the discrete bacterial...
3
21
49
Pleased to share our latest gastro publication from the Mehandru Lab in collaboration with @CArgmann and @Datadrivenmayte on SARS-CoV-2 receptor expression and overlapping gene networks in COVID response and IBD. https://t.co/RHWguDckUt
@SinaiImmunol #MehandruLab #COVID19
0
7
9
Excited to share our latest work from the Mehandru lab on gastrointestinal involvement in COVID-19 patients! @MountSinaiGI @SinaiImmunol @MSHS_IBDCenter
https://t.co/LojhNxQdHR
medrxiv.org
Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary manifestation of coronavirus disease 2019 (COVID-19), we investigated the impact of GI infection on disease pathogenesis in...
0
18
41